Anya Biopharm Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	May '26 May 7, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	1,355	2,347	1,849	-	-
Market Cap Growth	15.97%	26.96%	-	-	-
Enterprise Value	988	1,963	1,385	-	-
Last Close Price	27.60	47.80	37.65	-	-
PS Ratio	83.29	144.25	85.60	-	-
PB Ratio	3.36	5.83	3.96	-	-
P/TBV Ratio	3.41	5.91	4.00	-	-
EV/Sales Ratio	60.72	120.67	64.11	-	-
Debt / Equity Ratio	0.01	0.01	0.01	-1.24	-1.18
Net Debt / Equity Ratio	-0.91	-0.91	-0.96	-1.10	-1.14
Net Debt / EBITDA Ratio	6.46	6.46	10.69	-3.25	-1.63
Net Debt / FCF Ratio	5.19	5.19	14.94	-3.78	-1.42
Asset Turnover	0.04	0.04	0.09	0.14	-
Quick Ratio	47.27	47.27	41.45	0.11	0.05
Current Ratio	47.95	47.95	41.59	0.12	0.09
Return on Equity (ROE)	-14.72%	-14.72%	-19.20%	-	-
Return on Assets (ROA)	-8.14%	-8.14%	-10.64%	-105.84%	-
Return on Capital Employed (ROCE)	-14.40%	-14.40%	-9.10%	34.40%	71.50%
Earnings Yield	-4.72%	-2.73%	-2.00%	-	-
FCF Yield	-5.22%	-3.02%	-1.63%	-	-
Buyback Yield / Dilution	-48.38%	-48.38%	-1351.36%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.